Results 201 to 210 of about 1,894,460 (329)

Effect of SLE anti-T cell antibodies on regulatory T cells

, 1980
Tsuyoshi Sakane, Masaaki Honda, Shunichi Kumagai, Tokugoro Tsunematsu   +3 more
openalex   +2 more sources

Immune regulatory loops determine productive interactions within human T lymphocyte–dendritic cell clusters [PDF]

, 1999
Gernot Stuhler, Anke Zobywalski, Frank Grünebach, Peter Brossart, Volker L. Reichardt, Heidi Barth, Stefan Stevanović, Wolfram Brugger, Lothar Kanz, S F Schlossman   +9 more
openalex   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Hybrid regulatory T cells: camouflaged architects of tumor immunity. [PDF]

Front Immunol
Azimnasab-Sorkhabi P, Soltani-Asl M, Kfoury Junior JR, Ansa-Addo EA.   +3 more
europepmc   +1 more source

Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia

, 1994
Krzysztof Giannopoulos
openalex   +2 more sources

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Regulatory T Cells in Invasive Breast Cancer: Prognosis, Mechanisms and Therapy. [PDF]

Cancers (Basel)
Xu A, Ayoub S, Zhang H, Wu Y, Rau M, Ma X.   +5 more
europepmc   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Immunometabolism of regulatory T cells in cancer. [PDF]

Oncogene
Saravia J, Chi H.
europepmc   +1 more source

Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc.

, 1993
Susanne J. Szabo, Jennifer S. Gold, Theresa L. Murphy, Kenneth M. Murphy   +3 more
openalex   +1 more source